AF-710B
Founded in 2017, Sigma Chemical Co., Ltd. supplies over 100 countries with high-quality chemicals. We are dedicated to safety, innovation, and global cooperation.
Product Description
AF-710B, also known as Anavex 3-71 or AAE07Z061B, is a small-molecule drug candidate. It is a racemic mixture with one undefined stereocenter. AF-710B is an allosteric agonist of the M1 muscarinic receptor and σ1 receptor, making it a promising candidate for cognitive enhancement and disease-modifying effects in Alzheimer’s disease, as well as other neurological disorders like schizophrenia. It is soluble in DMSO and should be stored as a powder at −20 °C or in solution at −80 °C to maintain stability.
Biological Activity and Applications
-
Mechanism of Action: Allosteric agonist of the M1 muscarinic receptor and σ1 (sigma-1) receptor
-
Therapeutic Research Use: Investigated for cognitive enhancement and disease-modifying effects in Alzheimer’s disease, with preclinical models showing neuroprotective and cognition-boosting potential. Also studied in contexts like schizophrenia and other neurological disorders.
-
Clinical Development: As of August 2025, AF-710B (ANAVEX 3-71) is in clinical development, including a Phase 2 trial for schizophrenia that completed enrollment in May 2025, with top-line data expected later in the year. A Phase 1 first-in-human study was initiated in July 2024.
Uses
-
Primary Use: Investigational drug for the treatment of neurodegenerative diseases (Alzheimer’s disease) and neuropsychiatric disorders (schizophrenia).
-
Potential Applications: Cognitive enhancement, neuroprotection, and management of other neurological disorders.
Chemical Identity and Structure
-
IUPAC Name: 1-(2,8-dimethyl-1-thia-3,8-diazaspiro[4.5]decan-3-yl)-3-(1H-indol-3-yl)propan-1-one
-
Molecular Formula: C₂₀H₂₇N₃OS
-
Molecular Weight: 357.5 g/mol
-
CAS Registry Number: 1235733-73-9
-
InChI: InChI=1S/C20H27N3OS/c1-15-23(14-20(25-15)9-11-22(2)12-10-20)19(24)8-7-16-13-21-18-6-4-3-5-17(16)18/h3-6,13,15,21H,7-12,14H2,1-2H3
-
InChIKey: XWMHYQATSBWUNT-UHFFFAOYSA-N
-
SMILES: CC1N(CC2(S1)CCN(CC2)C)C(=O)CCC3=CNC4=CC=CC=C43
Physicochemical Properties
-
XLogP₃: 3.1 (lipophilicity estimate)
-
Topological Polar Surface Area (tPSA): 64.6 Ų
-
Hydrogen Bond Donors: 1
-
Hydrogen Bond Acceptors: 3
-
Rotatable Bonds: 3
-
Stereochemistry: Racemic mixture (one undefined stereocenter)
Solubility and Storage
-
Solubility: Soluble in DMSO
-
Physical Form: Solid at room temperature
-
Storage Conditions:
-
Powder: −20 °C (stable for years)
-
In solution: −80 °C up to 6–12 months
-
Safety and Regulation
-
Regulatory Status: Subject to strict regulatory oversight by agencies like the EPA (Environmental Protection Agency) in the U.S. and the EFSA (European Food Safety Authority) in the EU.
-
Guidelines: Specific guidelines on application rates, timing, and maximum residue limits (MRLs) in food products to ensure environmental and consumer safety.